Intuitive Surgical, Inc. (LON:0R29)
447.41
-1.30 (-0.29%)
At close: Oct 9, 2025
Intuitive Surgical Revenue
Intuitive Surgical had revenue of $2.44B USD in the quarter ending June 30, 2025, with 21.40% growth. This brings the company's revenue in the last twelve months to $9.15B, up 20.77% year-over-year. In the year 2024, Intuitive Surgical had annual revenue of $8.35B with 17.24% growth.
Revenue (ttm)
$9.15B
Revenue Growth
+20.77%
P/S Ratio
17.92
Revenue / Employee
$584.79K
Employees
15,638
Market Cap
119.61B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 8.35B | 1.23B | 17.24% |
Dec 31, 2023 | 7.12B | 901.90M | 14.49% |
Dec 31, 2022 | 6.22B | 512.10M | 8.97% |
Dec 31, 2021 | 5.71B | 1.35B | 31.01% |
Dec 31, 2020 | 4.36B | -120.10M | -2.68% |
Dec 31, 2019 | 4.48B | 754.30M | 20.25% |
Dec 31, 2018 | 3.72B | 586.00M | 18.67% |
Dec 31, 2017 | 3.14B | 431.70M | 15.95% |
Dec 31, 2016 | 2.71B | 322.10M | 13.51% |
Dec 31, 2015 | 2.38B | 252.70M | 11.85% |
Dec 31, 2014 | 2.13B | -133.40M | -5.89% |
Dec 31, 2013 | 2.27B | 86.30M | 3.96% |
Dec 31, 2012 | 2.18B | 421.50M | 23.99% |
Dec 31, 2011 | 1.76B | 344.30M | 24.37% |
Dec 31, 2010 | 1.41B | 360.80M | 34.29% |
Dec 31, 2009 | 1.05B | 177.30M | 20.27% |
Dec 31, 2008 | 874.90M | 274.07M | 45.62% |
Dec 31, 2007 | 600.83M | 228.15M | 61.22% |
Dec 31, 2006 | 372.68M | 145.34M | 63.93% |
Dec 31, 2005 | 227.34M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 41.24B |
GSK plc | 31.63B |
Haleon | 11.02B |
Smith & Nephew | 4.33B |
ConvaTec Group | 1.72B |
Hikma Pharmaceuticals | 2.35B |
HUTCHMED (China) | 439.54M |
Genus | 672.80M |
Intuitive Surgical News
- 1 day ago - ISRG Shares Rise as FDA Clears AI Integration for Ion Platform - Nasdaq
- 1 day ago - Guru Fundamental Report for ISRG - Martin Zweig - Nasdaq
- 1 day ago - 3 Magnificent Stocks to Buy That Are Near 52-Week Lows - Nasdaq
- 2 days ago - ISRG Bets on SP Platform to Capture Rising ASC Procedure Volume - Nasdaq
- 2 days ago - Intuitive Surgical (ISRG) Gains FDA Clearance for Ion System Enhancements - GuruFocus
- 2 days ago - Intuitive expands AI and advanced imaging integration in Ion Endoluminal System - GlobeNewsWire
- 3 days ago - ISRG: Evercore ISI Group Lowers Price Target to $450 | ISRG Stock News - GuruFocus
- 3 days ago - ISRG Quantitative Stock Analysis - Martin Zweig - Nasdaq